Remove 2030 Remove Pharmaceutical Manufacturing Remove Vaccines
article thumbnail

17th edition of CPHI & PMEC India inaugurated at India Expo Centre, Noida

Express Pharma

The 17th edition of CPHI & PMEC India, organised by Informa Markets in India opened its doors at the India Expo Centre, Greater Noida, Delhi-NCR, showcasing the robust potential of India’s pharmaceutical industry. Projections indicate exports will soar to $130 billion by 2030 and $450 billion by 2047. With exports nearing $27.84

Packaging 105
article thumbnail

Greening India’s industrial horizon: Navigating climate resilience in pharma and beyond

Express Pharma

India’s pharmaceutical industry is a global powerhouse. It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. India makes 60 per cent of the world’s vaccines and 20 per cent of the world’s generic drugs. Infections and diseases once easy to treat become dangerous.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

16th edition of CPHI & PMEC India Expo to be held from November 28-30, 2023, at India Expo Centre, Greater Noida

Express Pharma

The expo enjoys support from key industry associations such as Bulk Drug Manufacturing Association (BDMA), Federation of Pharma Entrepreneurs (FOPE), Karnataka Drugs and Pharmaceuticals Manufacturers’ Association (KDPMA), Organisation of Pharmaceutical Producers of India (OPPI), and Pharmaceutical Export Promotion Council (Pharmexcil).

Packaging 105
article thumbnail

Biotech titans Bengaluru and Hyderabad fortify India’s dominance

Express Pharma

The COVID-19 pandemic has further elevated the significance of this industry, spotlighting India’s role as a major global player in vaccine production and pharmaceutical R&D. Together, this has led to a surge in real estate demand that is likely to reach approximately 96 million sq ft by 2030 (1).

article thumbnail

Procuring HIV/AIDS medicines from African producers

Quality Matters

Given this dependence on foreign manufacturers, the African Union made regional production a central pillar of its New Public Health Order, and partnerships that support African-produced medicines, vaccines, and other medical products, are central to their efforts. But PEPFAR is looking to change how it does business.